Finland: Microwave News Article Archive (2004 - )

A new analysis from the radiation group at the International Agency for Research on Cancer (IARC) calls into question the agency’s own classification of wireless radiation as a possible human carcinogen.

On May 27, IARC’s Isabelle Deltour presented the new analysis of the incidence of malignant brain tumors (glioma) in the Nordic countries —Denmark, Finland, Norway and Sweden— over the last several decades. She spoke at an online colloquium hosted by the German Federal Office of Radiation Protection, known as the BfS.

Deltour argued that the trends are mostly not “compatible” with those seen in the epidemiological studies —principally, Interphone and Lennart Hardell’s— that were the basis of IARC’s 2011 designation of RF radiation as a possible, or 2B, human carcinogen.

The incidence of acoustic neuroma is not increasing in the Nordic countries, according to researchers from Denmark, Finland, Norway and Sweden. The team —made up of members of Interphone that don't believe that cell phones lead to tumors looked at cancer registry records from 1987 to 2007.

Their paper appears in the September 27 issue of the ...

Every now and then a new paper comes along that gives hope that one day we'll make sense of the conflicting results that have become the hallmark of EMF research. A team of Finnish researchers from the University of Kuopio has published such a paper. It's in the June issue of the International Journal of Radiation Biology.

Anne Höytö, Jukka Juutilainen and Jonne Naarala have shown that the type of cells used in in vitro studies can determine whether they will respond to RF radiation. They ran the same experiment with primary cells —those taken directly from an organism— and with secondary cells —those that have been grown in a petri dish. They exposed both types of cells to two different RF signals, CW and modulated (GSM), at various intensities (SAR =1.5, 2.5 or 6 W/Kg) for various amounts of time (2, 8 or 24 hr), and then measured the activity of ODC (ornithine decarboxylase), an enzyme related to cellular growth and differentiation.

Dariusz Leszczynski, of the Radiation and Nuclear Safety Authority ( STUK) in Helsinki, has been appointed Guangbiao Professor at China's Zhejiang University Medical School. Over the next three years, Leszczynski will spend one month each year at the university's Bioelectromagnetics Lab, where he will collaborate with Zhengping Xu. Together, they will focus on the effects of cell phone radiation on human proteins. At the same time, Leszczynski will continue to serve as the head of STUK's radiation biology lab, where he has been a leader in applying proteomic and transcriptomic techniques to the study of RF biological effects.